Ccl5 establishes an autocrine high-grade glioma growth regulatory circuit critical for mesenchymal glioblastoma survival [PDF]
Gutmann, David H +4 more
core +2 more sources
Neurofibromatosis Type 2: A Rare Case of Multiple Intracranial Schwannomas, Meningiomas, and Ependymomas (MISME) Syndrome and Literature Review. [PDF]
Hamza L +5 more
europepmc +1 more source
Subacute brainstem ischemic syndrome in juvenile neurofibromatosis type 2: An underrecognized condition. [PDF]
Blauen A +3 more
europepmc +1 more source
Management Strategies of Neurofibromatosis Type 2 in Pediatric Patients : Challenges and Emerging Therapies. [PDF]
Lee JS.
europepmc +1 more source
Efficacy of Combined Dabrafenib and Trametinib Therapy in BRAFV600E Mutant Intrahepatic Cholangiocarcinoma with a Neurofibromatosis Type 2 Mutation. [PDF]
Yoshida J +13 more
europepmc +1 more source
Bevacizumab for Vestibular Schwannomas in Neurofibromatosis Type 2: A Systematic Review of Tumor Control and Hearing Preservation. [PDF]
Screnci M +5 more
europepmc +1 more source
KIR2DL5 mutation and loss underlies sporadic dermal neurofibroma pathogenesis and growth [PDF]
Anastasaki, Corina +2 more
core +3 more sources
Erratum: Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2. [PDF]
Prabhakar S +15 more
europepmc +1 more source
Oncogenetic testing, diagnosis and follow-up in Birt-Hogg-Dubé syndrome, familial atypical multiple mole melanoma syndrome and neurofibromatosis 1 and 2 [PDF]
't Kint de Roodenbeke, Daphné +13 more
core
Neurofibromatosis Type 2 Presenting as Symptomatic Gallbladder Hydrops: A Rare Case Report and Literature Review. [PDF]
Hafez B +6 more
europepmc +1 more source

